Crestline Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13	Closed	-$251K	–	272
2022 Q2	$251K	Buy	+13	New	+$251K	0.03%	191